Xeris Pharmaceuticals | XERS - Ordinary Share Capital



Xeris Pharmaceuticals reported $161.22M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Adcock Ingram Holdings ZAR 14.68M 0 Dec/2024
Celltrion KRW 230.8B 10.29B Mar/2025
Cspc Pharmaceutical CNY 11.03B 26.91M Dec/2024
Dianthus Therapeutics USD 32.18M 32.15M Jun/2025
Divis Laboratories Ltd 530M 0 Mar/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Kangmei Pharma CNY 13.86B 0 Jun/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Laboratorios Farma EUR 3.24M 0 Jun/2023
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Organigram Holdings CAD 134.02M 758.57M Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 6.56B Jun/2025
Pharma Mar EUR 17.58M 6.64M Jun/2025
Qiagen NV USD 216.83M 214.3M Jun/2025
Sartorius EUR 69.04M 38.2K Jun/2025
Sino Biopharmaceutical CNY 414.38M 0 Dec/2024
Supernus Pharmaceuticals USD 56.12M 130K Jun/2025
Tilray USD 93K 5K Nov/2024
Zz Pientze Pharmaceu 603.32M 0 Jun/2025